Cassava Sciences Inc (SAVA)
25.87
-0.34
(-1.30%)
USD |
NASDAQ |
Nov 04, 16:00
26.00
+0.13
(+0.50%)
After-Hours: 20:00
Cassava Sciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2007 | 0.00 |
| June 30, 2007 | 0.00 |
| March 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| September 30, 2006 | 0.00 |
| June 30, 2006 | 0.00 |
| March 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| September 30, 2005 | 0.00 |
| June 30, 2005 | 0.00 |
| March 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| September 30, 2004 | 0.00 |
| June 30, 2004 | 0.00 |
| March 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| September 30, 2003 | 0.00 |
| June 30, 2003 | 0.00 |
| March 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| September 30, 2002 | 0.00 |
| June 30, 2002 | 0.00 |
| March 31, 2002 | 0.00 |
| December 31, 2001 | 0.00 |
| September 30, 2001 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Bristol-Myers Squibb Co | 2.902 |
| Eli Lilly and Co | 2.185 |
| Seelos Therapeutics Inc | -- |
| Biomarin Pharmaceutical Inc | 0.1098 |
| EyePoint Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 243.57M |
| Total Liabilities (Quarterly) | 54.59M |
| Shareholders Equity (Quarterly) | 188.97M |